Alumis Announces Pricing of Initial Public Offering
27 juin 2024 23h57 HE
|
Alumis Inc.
Alumis, a clinical-stage biopharmaceutical company developing oral therapies for immune mediated diseases, announces pricing of initial public offering
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease
22 mai 2024 06h55 HE
|
ANTION BIOSCIENCES SA
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
17 mai 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
13 mai 2024 08h00 HE
|
Exagen Inc.
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
14 mars 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
07 mars 2024 16h05 HE
|
Exagen Inc.
CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31,...
$6.24 Billion Multiplex Assays Markets: Oncology, Cardiovascular, Infectious, Autoimmune Diseases - Global Forecast to 2030: Integration of AI and ML Gaining Momentum
01 mars 2024 03h53 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D,...
Global Scleroderma Market Forecasts Promising Growth with Latest Industry Trends by 2027
30 janv. 2024 20h25 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Scleroderma Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global scleroderma market is poised for...
Autolus Therapeutics to host virtual event to discuss the company’s obe-cel program in systemic lupus erythematosus
17 oct. 2023 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics to host virtual event to discuss the company’s obe-cel program in systemic lupus erythematosus
Addressing Unmet Needs: The SLE Market Grows as Research and Development Flourish
06 oct. 2023 06h08 HE
|
Research and Markets
Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with...